Patisiran (pat i SIR an) is used to treat nerve pain, tingling, numbness, and weakness due to a genetic disorder called hereditary transthyretin-mediated amyloidosis (hATTR).


ONPATTRO Information

En Español En Español

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.